Global C-Reactive Protein Testing Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities

The C-Reactive Protein Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

How Big Is the C-Reactive Protein Testing Market Size Expected to Be by 2034?
Over the past few years, the market size for c-reactive protein testing has seen consistent growth. Projected to rise from $3.45 billion in 2024 to $3.55 billion in 2025, it promises a compound annual growth rate (CAGR) of 2.9%. This past growth can be connected to a surge in the occurrence of inflammatory diseases, assessment of cardiovascular risk, growth in the elderly population, enhancement of healthcare infrastructure, and commencement of healthcare screening initiatives.

Anticipated robust growth in the coming years is expected for the c-reactive protein testing market, with a projected rise to $4.35 billion by 2029, reflecting a compound annual growth rate (CAGR) of 5.2%. This upward trend in the predicted timeframe can be traced back to factors like increased obesity levels, personalized medicine and biomarkers, telehealth and remote patient monitoring, early detection of diseases, and inflammation related to lifestyle habits. The period is also expected to witness key trends such as advancements in diagnostic testing, proliferation of wearable health technology, technological solutions, strategic alliances, and the launch of the industry 4.0.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6719

What Are the Emerging Segments Within the C-Reactive Protein Testing Market?
The c-reactive protein testing market covered in this report is segmented -

1) By Assay Type: Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assays
2) By Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, Cancer, Other Applications
3) By End Use: Clinics, Hospitals, Diagnostic Laboratories

Subsegments:
1) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA, Indirect ELISA, Sandwich ELISA
2) By Chemiluminescence Immunoassay (CLIA): Luminometer-Based CLIA, Automated CLIA Systems
3) By Immunoturbidimetric Assays: Nephelometry-Based Immunoturbidimetric Assays, Latex Agglutination Immunoturbidimetric Assays

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6719&type=smp

What Long-Term Drivers Are Shaping C-Reactive Protein Testing Market Trends?
The burgeoning incidences of cardiovascular diseases (CVD) are anticipated to spur the advancement of the c-reactive protein testing market. The term CVD encompasses heart-related conditions, including problematic blood vessels, anatomical issues, and blood coagulations. The precise root of CVD remains unknown, but numerous elements can heighten the development risk. Behavioral risk factors, like imbalanced diet, insufficient physical exercise, smoking, and alcohol consumption, result in a buildup of fat within the blood vessels (atherosclerosis), elevating the odds of blood clot formation. These behaviors lead to increased blood pressure, blood sugar levels, blood lipid levels, weight gain, and obesity. The growing prevalence of cardiovascular diseases necessitates the utility of c-reactive protein testing in diagnosing or forecasting the likelihood of encountering heart-related issues at least on par with cholesterol levels. For instance, data from the Institute for Health Metrics and Evaluation in December 2023 revealed that global fatalities due to cardiovascular diseases (CVDs) hit 19.8 million in 2022, with ischemic heart disease contributing the highest number of deaths at 108.8 per 100,000 individuals. High systolic blood pressure was a significant contributor to disability-adjusted life years (DALYs) tied to CVD, with diet risks and air pollution being primary behavioral and environmental contributors to this global burden.

Who Are the Top Competitors in Key C-Reactive Protein Testing Market Segments?
Major companies operating in the c-reactive protein testing market include Thermo Fisher Scientific Inc., F Hoffmann-La Roche AG, Danaher Corporation, Quest Diagnostics Incorporated, Siemens AG, Abbott Laboratories, Aidian Oy, Boditech Med Inc., Horiba Ltd., Laboratory Corporation, Merck KGAA, Randox Laboratories Limited, Getein Biotech Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., Eurofins Scientific SE, Inova Diagnostics Inc., Luminex Corporation, Sekisui Diagnostics LLC, Sysmex Corporation, Tosoh Corporation, Trinity Biotech Plc, WerfenLife Group LLC, ZEUS Scientific Inc., BioMérieux SA, Biomerica Inc., Gold Standard Diagnostics Corp., Immunodiagnostic Systems Holdings PLC, Nova Biomedical Corporation

What C-Reactive Protein Testing Market Trends Are Gaining Traction Across Different Segments?
The advancement of technology in testing devices is a significant trend in the c-reactive protein testing market. The top businesses in this market are striving to offer high-tech solutions to solidify their position in the market. The implementation of cutting-edge c-reactive testing technologies in their testing procedures and sophisticated solutions is providing advantages like increased productivity and multipurpose usage. For instance, Aidian, a Finnish firm specializing in diagnostic tests and test solutions, unveiled the QuikRead go wrCRP & wrCRP+Hb kits in February 2022. This kit reliably gives dual results, covering a broad spectrum of CRP and Hb from a single sample using one analysis. The expanded range CRP test facilitates CRP measurement to evaluate conditions such as neonatal sepsis, anticipates the severity extent in COPD (chronic obstructive pulmonary disease), and aids in assessing cardiovascular risk.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report

Which Regions Are Becoming Hubs for C-Reactive Protein Testing Market Innovation?
North America was the largest region in the c-reactive protein testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the c-reactive protein testing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the C-Reactive Protein Testing Market?
2. What is the CAGR expected in the C-Reactive Protein Testing Market?
3. What Are the Key Innovations Transforming the C-Reactive Protein Testing Industry?
4. Which Region Is Leading the C-Reactive Protein Testing Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.